The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa (scientific article published on January 2012)

Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi

Q28387497

Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration

Q33692808

Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus

Q33817605

Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors

Q33883605

Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance

Q33992235

Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial.

Q44959514

Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients

Q45229364

Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya.

Q46316323

Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe

Q46348110

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi

Q46428335

HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa

Q46538463

Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya

Q46741853

Increased prevalence of severe malaria in HIV-infected adults in South Africa

Q46977081

The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya

Q47923816

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis

Q47975940

The potential for interactions between antimalarial and antiretroviral drugs

Q48010230

Hepatotoxicity Due to a Drug Interaction between Amodiaquine plus Artesunate and Efavirenz

Q56833699

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

Q57877986

Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa

Q59689434

Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi

Q62487042

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

Q64131962

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

Q34359439

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

Q34369756

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

Q34482190

In vitro activity of antiretroviral drugs against Plasmodium falciparum

Q35363679

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

Q35598594

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults

Q35883504

Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment

Q36834927

The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance

Q36840133

Increased risk for severe malaria in HIV-1-infected adults, Zambia

Q37203716

Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease

Q37339874

Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers

Q37364219

Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda

Q37429678

HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea

Q38868223

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

Q38872771

Insecticide resistance and its association with target-site mutations in natural populations of Anopheles gambiae from eastern Uganda

Q38874713

High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda

Q38876341

Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children

Q38877477

Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study

Q38879589

Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study

Q38880071

HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study.

Q38884784

Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

Q38885142

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.

Q38912058

Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study

Q39532443

Malaria therapy in HIV: drug interactions between nevirapine and quinine

Q39544185

HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria

Q39550259

Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control

Q39558033

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

Q39588620

HIV infection, malaria, and pregnancy: a prospective cohort study in Kigali, Rwanda.

Q39608925

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers

Q39972769

HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.

Q40465603

Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi

Q40486195

Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi

Q40500913

Association of HIV infection with the development of severe and complicated malaria cases at a rural hospital in Zimbabwe.

Q40543075

Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali

Q41913039

Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations

Q43646776

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

Q43836224

Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors.

Q44364822

HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya

Q44394085

Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey.

Q44635990

P433

issue

P921

main subject

malaria

Q12156

P304

page(s)

699-708

P577

publication date

2012-01-01

P1433

published in

Future Virology

Q15751230

P1476

title

The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa

P478

volume

Reverse relations

cites work (P2860)

Q34996394	"Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania
Q46564382	Burden of asymptomatic malaria, anemia and relationship with cotrimoxazole use and CD4 cell count among HIV1-infected adults living in Gabon, Central Africa
Q27009235	Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis
Q40144262	Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study
Q24288875	Genetic diversity of Plasmodium falciparum isolates from concurrent malaria and arbovirus co-infections in Kedougou, southeastern Senegal
Q39052051	HIV-1 infection and antibodies to Plasmodium falciparum in adults
Q34493927	Prevalence of clinically captured and confirmed malaria among HIV seropositve clinic attendants in five hospitals in Ghana
Q91672252	Prevalence of malaria in HIV positive and HIV negative pregnant women attending antenatal clinics in south eastern Nigeria
Q38860717	Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial